Stock Market & Financial Investment News

Intercept intends to file for accelerated approval in PBCIntercept said in conference presentation slides that it intends to file for accelerated approval for OCA in primary biliary cirrhosis, or PBC, conditional on conducting an additional Phase 3 confirmatory clinical outcomes trial for full approval.